Drug Injury

The risk of amputation has led to an Invokana warning on this popular diabetes drug. The U.S. Food and Drug Administration has stated that the high risk of amputation has prompted a new Invokana warning label. These black box warnings will explain that patients may have a much higher risk of needing their feet or […]

Instances of Invokana kidney failure have led to a number of different patients filing lawsuits against the manufacturer of the drug. A new class of diabetes drugs that was promoted as safe and effective have been named in a number of different lawsuits based on severe side effects. One such example of these side effects

The next major case in a consolidated Xarelto blood thinner lawsuit will rely on expert witness testimony from physicians. The prescribing physicians’ testimony is expected to be very influential in the outcome of this second Philadelphia blood thinner lawsuit. This is not the first time that a physician’s insight will be influential in the case

The FDA has recently confirmed a higher risk of foot and leg amputations with the diabetes medication Canagliflozin and this has led to a new Invokana amputation lawsuit. The drugs Invokamet XR, Invokamet, and Invokana are all forms of Canagliflozin and have been tied to increased patient reports about severe risk of amputation after continued

Defendants concerned about the fallout of a Xarelto lawsuit are asking a Pennsylvania judge to bar a complaint. The master complaint is part of a mass tort program regarding the popular blood-thinner. Many patients who have used the medication report serious side effects and claim they were never told by the company or their doctors

An Invokana injury lawsuit accuses Janssen Pharmaceuticals of failing to warn the medical community and patients about the risk of severe Invokana side effects. Invokana is an SLGT-2 inhibitor that is typically ingested by patients to treat type 2 diabetes. Those patients who ingested the drug and sustained an Invokana injury may find this out in

A lawsuit alleges that a Washington man suffered severe rectal bleeding in November 2015 after taking Xarelto. According to the Xarelto bleeding lawsuit, the plaintiff took the drug from approximately June 12, 2014 until Nov. 9, 2015. The plaintiff says he suffered severe injuries from taking Xarelto and began suffering from rectal bleeding at that

A nonprofit reports that its study of CDC mortality data reveals the economic cost of the opioid epidemic since 2001 is $1 trillion. According to Altarum’s Center for Value and Health Care, lost earnings and productivity, as well as increased medical expenses led to the startlingly high cost of opioid use in the United States

An Illinois resident has recently come forward to share that he believes that his opioid addiction is because of the painkiller’s representative supporting the drug without mentioning the dangerous downside.  According to the opioid addiction lawsuit, the company responsible for making Subsys, Insys Therapeutics, allegedly promoted the drug without giving patients or doctors a clear idea of the dangers associated

The number of Xarelto lawsuits has increased in recent years, as more patients come forward with claims of serious side effects such as excessive vaginal bleeding and more. A North Carolina woman has filed a Xarelto injury lawsuit against the manufacturers of the drug. She claims that they knew about the serious risks of bleeding

Determining who is responsible for the opioid crisis is the latest focus in a series of lawsuits and investigations. Many manufacturers have been blamed for this crisis that’s sweeping the United States leading to significant health care costs and other expenses associated to the epidemic. The opioid crisis has had ripple effects throughout the United

The opioid epidemic is increasingly reaching the youngest and most vulnerable members in America – children. According to recent reports from children’s hospitals, opioid injuries in children are increasing. Researchers looked at pediatric hospitalizations for opioid ingestion for over a decade and found that between 2004 and 2015 the number doubled. Researchers analyzed data from

A judge presiding over all current opioid litigation recently scheduled a conference that would focus completely on settlement opportunities for a resolution. Opioid litigation has been on the rise in recent months as various parties come together to allege that manufacturers are responsible for the opioid crisis that has swept the country. These lawsuits are

A lawsuit alleges that a Pennsylvania man suffered a gastrointestinal hemorrhage as a direct result of taking Xarelto. According to the lawsuit, the plaintiff was prescribed Xarelto from February 2016 to August 2016. The plaintiff alleges he suffered a gastrointestinal hemorrhage from taking the drug for less than one year. Ultimately, says the plaintiff, he

A lawsuit has been filed on behalf of a patient who allegedly suffered fatal injuries because of life-threatening bleeding from Xarelto. The plaintiff, who is representing the deceased individual, alleges that manufacturer Janssen Research and Development knew about severe bleeding risks but failed to warn the public and medical community about the dangers. The dangerous